Cargando…

Correction to: Potential therapeutic targets for sarcopenia identified by Mendelian randomisation

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200548/ https://www.ncbi.nlm.nih.gov/pubmed/37211366 http://dx.doi.org/10.1093/ageing/afad047

Ejemplares similares

Potential therapeutic targets for sarcopenia identified by Mendelian randomisation
por: Jiang, Wei, et al.
Publicado: (2023)

Correction: Obesity and risk of female reproductive conditions: A Mendelian randomisation study
por: Venkatesh, Samvida S., et al.
Publicado: (2022)

Correction: Mendelian and Non-Mendelian Regulation of Gene Expression in Maize
por: Li, Lin, et al.
Publicado: (2018)

Correction to: Investigating the Causal risk Factors for self-harm by Integrating Mendelian Randomisation Within twin Modelling
por: Lim, Kai Xiang, et al.
Publicado: (2022)

Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s disease
por: Su, Wei-Ming, et al.
Publicado: (2023)

Education and myopia: assessing the direction of causality by mendelian randomisation
Publicado: (2018)

Correction: Use machine learning to help identify possible sarcopenia cases in maintenance hemodialysis patients
por: Liao, Hualong, et al.
Publicado: (2023)

Correction: Targeted Next-Generation Sequencing for Clinical Diagnosis of 561 Mendelian Diseases
por: Liu, Yanqiu, et al.
Publicado: (2016)

Correction: Targeted Next-Generation Sequencing for Clinical Diagnosis of 561 Mendelian Diseases
por: Liu, Yanqiu, et al.
Publicado: (2015)

Publisher Correction: Mendelian randomisation study of the relationship between vitamin D and risk of glioma
por: Takahashi, Hannah, et al.
Publicado: (2019)

Correction: Ultrasound assessment of degenerative muscle sarcopenia: the University of Barcelona ultrasound scoring system for sarcopenia
Publicado: (2023)

Correction: Ultrasound assessment of degenerative muscle Sarcopenia: the university of barcelona ultrasound scoring system for Sarcopenia
Publicado: (2023)

Correction: Type I Interferon: Potential Therapeutic Target for Psoriasis?
por: Yao, Yihong, et al.
Publicado: (2009)

Correction: Integrative Omics Analysis of Rheumatoid Arthritis Identifies Non-Obvious Therapeutic Targets
por: Whitaker, John W., et al.
Publicado: (2015)

Correction for Zhou et al., Dysregulation of PD-L1 by UFMylation imparts tumor immune evasion and identified as a potential therapeutic target
Publicado: (2023)

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
Publicado: (2015)

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
por: Zhang, Hao, et al.
Publicado: (2020)

Correction: Creatinine‑to‑cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
por: Dai, Huifang, et al.
Publicado: (2022)

Author Correction: Mendelian neurodegenerative disease genes involved in autophagy
por: Stamatakou, Eleanna, et al.
Publicado: (2020)

Correction to: A validated single-cell-based strategy to identify diagnostic and therapeutic targets in complex diseases
por: Gawel, Danuta R., et al.
Publicado: (2020)

Putative Candidate Drug Targets for Sarcopenia-Related Traits Identified Through Mendelian Randomization Analysis of the Blood Proteome
por: Chen, Bin-Bin, et al.
Publicado: (2022)

Correction: Parkin-mediated mitophagy as a potential therapeutic target for intervertebral disc degeneration
por: Zhang, Zengjie, et al.
Publicado: (2021)

Correction for Kim et al., Silver electroceutical technology to treat sarcopenia
Publicado: (2023)

Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
por: Berk, Michael, et al.
Publicado: (2019)

Correction to: PiggyBac mutagenesis and exome sequencing identify genetic driver landscapes and potential therapeutic targets of EGFR-mutant gliomas
por: Noorani, Imran, et al.
Publicado: (2020)

Correction: Mitosis Is a Source of Potential Markers for Screening and Survival and Therapeutic Targets in Cervical Cancer
por: Espinosa, Ana María, et al.
Publicado: (2013)

Correction: Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study
por: Mokry, Lauren E., et al.
Publicado: (2016)

Correction: Homozygosity mapping provides supporting evidence of pathogenicity in recessive Mendelian disease
por: Wakeling, Matthew Neil, et al.
Publicado: (2018)

Correction: Gene Expression Profiling Identifies Molecular Pathways Associated with Collagen VI Deficiency and Provides Novel Therapeutic Targets
por: Paco, Sonia, et al.
Publicado: (2015)

Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target
por: Cook, Peter J., et al.
Publicado: (2018)

Correction: Lifelong Reduction of LDL-Cholesterol Related to a Common Variant in the LDL-Receptor Gene Decreases the Risk of Coronary Artery Disease—A Mendelian Randomisation Study
por: Linsel-Nitschke, Patrick, et al.
Publicado: (2008)

Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization
por: Henry, Albert, et al.
Publicado: (2022)

Correction: therapeutic effect of palbociclib in chondrosarcoma: implication of cyclin-dependent kinase 4 as a potential target
por: Ouyang, Zhengxiao, et al.
Publicado: (2023)

Correction: Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
por: Cortez, Valerie, et al.
Publicado: (2012)

Correction: Effect of Insulin Resistance on Monounsaturated Fatty Acid Levels: A Multi-cohort Non-targeted Metabolomics and Mendelian Randomization Study
por: Nowak, Christoph, et al.
Publicado: (2017)

Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies
Publicado: (2017)

Correction: Interleukin-6: a new therapeutic target
por: Smolen, Josef S, et al.
Publicado: (2006)

Correction: Serum Iron Levels and the Risk of Parkinson Disease: A Mendelian Randomization Study
por: Pichler, Irene, et al.
Publicado: (2013)

Correction: Clinical epigenomics: genome-wide DNA methylation analysis for the diagnosis of Mendelian disorders
por: Sadikovic, Bekim, et al.
Publicado: (2021)

Correction: Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma
por: Gruber, Elisabeth S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ia8epukos754v4v4u1p1tug0js